KemOne has newly appeared among the top searched stocks.
As of 1:30 PM on the 20th, KemOne is trading at 3,705 KRW, down 6.68% from the previous day. This represents a 30.69% increase compared to September 24. KemOne is known as the first non-clinical CRO company in Korea.
Over the past five days, individual investors have net sold 288,727 shares, while foreigners and institutions have net bought 19,917 shares and 252,626 shares, respectively.
On October 19, KemOne became a market issue with the headline "15%↑ due to the 'outsourcing' trend of COVID-19 vaccines."

※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![User Who Sold Erroneously Deposited Bitcoins to Repay Debt and Fund Entertainment... What Did the Supreme Court Decide in 2021? [Legal Issue Check]](https://cwcontent.asiae.co.kr/asiaresize/183/2026020910431234020_1770601391.png)
